Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR)

CAPS Rating: 4 out of 5

Caps

How do you think EIGR will perform against the market?

Add Stock to CAPS Watchlist

All Players

29 Outperform
3 Underperform
 

All-Star Players

4 Outperform
0 Underperform
 

Wall Street

2 Outperform
0 Underperform
 

Top EIGR Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Deepvaluestocks (< 20)
Submitted June 30, 2015

With market expectations now at rock-bottom thanks to Friday's press release, I believe now is a good time to initiate a position in Celladon.

Jordrok (89.81)
Submitted January 02, 2015

No revenues... yet.

EIGR VS S&P 500 (SPY)

Fools bullish on EIGR are also bullish on:

Fools bearish on EIGR are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about EIGR.

Recs

0
Member Avatar oscillation (75.94) Submitted: 5/28/2015 9:24:56 AM : Outperform Start Price: $32.40 EIGR Score: -88.20

nev

Recs

0
Member Avatar treasureoaks (23.21) Submitted: 4/22/2015 3:54:19 PM : Outperform Start Price: $203.85 EIGR Score: -118.18

Oversold.

Recs

0
Member Avatar Jimbyrnes1969 (< 20) Submitted: 4/9/2015 1:25:22 PM : Outperform Start Price: $252.36 EIGR Score: -120.64

I believe the Mydicar therapy is revolutionary and will help to boost Celladon's stock price much higher in relation to the market over the next 2-4 years. The Cupid2 study results being released later this month- if positive, will propel the stock 300% in the short term but the real value will be when the therapy hits the market.

Leaderboard

Find the members with the highest scoring picks in EIGR.

Score Leader

naughtyguy

naughtyguy (33.81) Score: +166.55

No products in their pipeline that have reached phase 3. This usually means a long time before any money is made and going through a lot of cash needing to offer more stock for sale to raise cash. Investors will be impatient and invest elsewhere.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
GreenAB 76.07 3/20/2015 Underperform NS $405.00 -97.24% +24.06% +121.30 0 Comment
WSMOOT19 71.36 5/1/2015 7/14/2017 Underperform 1Y $40.05 -72.11% +24.39% +96.50 0 Comment
IdahoInvestor 32.32 8/17/2015 Underperform 5Y $15.75 -29.08% +24.80% +53.88 0 Comment
Playa14 < 20 1/16/2018 Outperform 5Y $8.48 +31.74% -6.41% +38.15 0 Comment
hayrettin 70.47 2/5/2018 Outperform 5Y $8.55 +30.64% -3.71% +34.35 0 Comment
BigDreamer 55.14 1/29/2018 Outperform 3Y $8.95 +24.80% -8.90% +33.71 0 Comment
drcor < 20 1/23/2018 Outperform 3M $8.90 +25.51% -8.09% +33.60 0 Comment
skyrocket29 47.97 1/16/2018 Outperform 3M $9.10 +22.75% -6.89% +29.64 0 Comment
portefeuille 98.38 3/22/2018 Outperform 5Y $9.95 +12.26% -2.30% +14.56 0 Comment
jeepdrew222 63.95 8/28/2018 Outperform 5Y $12.90 -13.41% -10.28% -3.14 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackJimCramer 85.30 3/20/2015 Outperform 3W $394.20 -97.17% +23.79% -120.96 0 Comment
TrackBWS 96.92 3/19/2014 Outperform NS $197.25 +13.76% +3.89% +9.88 6/18/2014 @ $224.40 0 Comment
TrackBarclaysCap 88.78 2/24/2014 Outperform NS $137.55 -91.88% +41.34% -133.22 0 Comment

Advertisement